Lululemon Athletica inc (LULU) concluded trading on Thursday at a closing price of $344.81, with 4.13 million shares of worth about $1.42 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.74% during that period and on December 05, 2024 the price saw a gain of about 0.74%. Currently the company’s common shares owned by public are about 118.61M shares, out of which, 107.09M shares are available for trading.
Stock saw a price change of 7.91% in past 5 days and over the past one month there was a price change of 8.01%. Year-to-date (YTD), LULU shares are showing a performance of -32.56% which decreased to -24.54% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $226.01 but also hit the highest price of $516.39 during that period. The average intraday trading volume for Lululemon Athletica inc shares is 1.90 million. The stock is currently trading 7.06% above its 20-day simple moving average (SMA20), while that difference is up 14.03% for SMA50 and it goes to 7.75% higher than SMA200.
Lululemon Athletica inc (NASDAQ: LULU) currently have 118.61M outstanding shares and institutions hold larger chunk of about 82.78% of that.
The stock has a current market capitalization of $44.10B and its 3Y-monthly beta is at 1.23. PE ratio of stock for trailing 12 months is 26.64, while it has posted earnings per share of $12.94 in the same period. Its PEG reads 2.91 and has Quick Ratio of 1.46 while making debt-to-equity ratio of 0.36. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LULU, volatility over the week remained 3.00% while standing at 3.27% over the month.
Stock’s fiscal year EPS is expected to rise by 9.41% while it is estimated to increase by 7.31% in next year. EPS is likely to shrink at an annualized rate of 9.16% for next 5-years, compared to annual growth of 27.57% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on December 02, 2024 offering an Underperform rating for the stock and assigned a target price of $220 to it. On October 01, 2024, Morgan Stanley Reiterated their recommendations, while on August 28, 2024, Wedbush Reiterated their ratings for the stock with a price target of $324. Stock get an Outperform rating from Telsey Advisory Group on August 26, 2024.
